| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/26/2001 | WO2001029214A1 Colon-tumour-associated antigens |
| 04/26/2001 | WO2001029213A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 04/26/2001 | WO2001029200A1 DNA ENCODING ENDO-β-GALACTOSIDASE |
| 04/26/2001 | WO2001029199A1 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 04/26/2001 | WO2001029198A1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase |
| 04/26/2001 | WO2001029194A1 Porcine endogenous retrovirus (poerv) expressed in guinea pig and corresponding animal models |
| 04/26/2001 | WO2001029193A2 Cell constructs that are suitable for immunotherapy, the production and the use thereof |
| 04/26/2001 | WO2001029192A2 Use of allogeneic cell lines to load antigen-presenting cells to elicit or eliminate immune responses |
| 04/26/2001 | WO2001029191A1 Method of in vitro culture of lymphocytes and gene therapy compositions |
| 04/26/2001 | WO2001029190A1 New lymphocytes, a process for preparing the same and their use in therapeutics |
| 04/26/2001 | WO2001029178A2 Epo primary response gene 1, eprg1 |
| 04/26/2001 | WO2001029129A1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 04/26/2001 | WO2001029081A1 Modified peptides and peptidomimetics for use in immunotherapy |
| 04/26/2001 | WO2001029079A1 IMMUNO-INTERACTIVE FRAGMENTS OF THE αC SUBUNIT OF INHIBIN |
| 04/26/2001 | WO2001029078A2 Method for production and use of mite group 1 proteins |
| 04/26/2001 | WO2001029071A2 Genes associated with obesity and methods for using the same |
| 04/26/2001 | WO2001029070A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | WO2001029064A2 Melanoma antigens and methods of use |
| 04/26/2001 | WO2001029056A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | WO2001028993A2 Tyrosine kinase inhibitors |
| 04/26/2001 | WO2001028585A1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 04/26/2001 | WO2001028583A2 Melanoma vaccine and methods of making and using same |
| 04/26/2001 | WO2001028543A1 TREATMENT OF EOSINOPHIL ASSOCIATED PATHOLOGIES BY MODULATING PKC-δ ACTIVITY |
| 04/26/2001 | WO2001028529A1 Pharmaceutical products and methods of fabrication therefor |
| 04/26/2001 | WO2001009335A3 Moraxella catarrhalis antigen basb120 |
| 04/26/2001 | WO2001005970A3 Gtp-binding protein associated factors |
| 04/26/2001 | WO2001005934A3 Feline calicivirus genes and vaccines, in particular recombined vaccines |
| 04/26/2001 | WO2000067787A3 Hiv immunogenic compositions and methods |
| 04/26/2001 | WO2000061612A3 Compounds and methods for therapy and diagnosis of lung cancer |
| 04/26/2001 | WO2000061151A3 Oligodeoxynucleotide and its use to induce an immune response |
| 04/26/2001 | WO2000056889A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/26/2001 | WO1997035884A8 Improved production of antibodies through the use of combinations of antigen and antibody, test kits incorporating said antibodies, and medical uses of said antibodies |
| 04/26/2001 | DE19949594A1 Rekombinante attenuierte Listerien zur Immuntherapie Recombinant attenuated Listeria for immunotherapy |
| 04/26/2001 | CA2389317A1 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | CA2388450A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | CA2387928A1 Genes associated with obesity and methods for using the same |
| 04/26/2001 | CA2387855A1 Melanoma vaccine and methods of making and using same |
| 04/26/2001 | CA2387840A1 Tyrosine kinase inhibitors |
| 04/26/2001 | CA2387786A1 Treatment of eosinophil associated pathologies by modulating pkc-.delta. activity |
| 04/26/2001 | CA2387392A1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase |
| 04/26/2001 | CA2387043A1 Colon-tumour-associated antigens |
| 04/26/2001 | CA2387041A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 04/26/2001 | CA2386922A1 Novel polypeptides and polynucleotides encoding same |
| 04/26/2001 | CA2386415A1 New lymphocytes, a process for preparing the same and their use in therapeutics |
| 04/26/2001 | CA2386398A1 Modified peptides and peptidomimetics for use in immunotherapy |
| 04/26/2001 | CA2384844A1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 04/25/2001 | EP1094110A1 Apoptosis inducing proteinaceous substance |
| 04/25/2001 | EP1094109A2 Human G protein-coupled receptor, PFI-010 |
| 04/25/2001 | EP1094108A2 DNA mutagenesis by random fragmentation and reassembly for antibody production |
| 04/25/2001 | EP1094076A1 Human G-protein coupled receptor |
| 04/25/2001 | EP1094075A1 Human G-protein coupled receptor |
| 04/25/2001 | EP1094070A2 Lawsonia intracellularis proteins, and related methods and materials |
| 04/25/2001 | EP1094069A1 DNA encoding structural protein-1 of infectious salmon anaemia virus and uses thereof |
| 04/25/2001 | EP1093822A2 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 04/25/2001 | EP1093821A2 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 04/25/2001 | EP1093820A2 Oral immunology using plant product containing hepatitis surface antigen |
| 04/25/2001 | EP1093819A2 Compounds and compositions for delivering active agents |
| 04/25/2001 | EP1093818A1 Powdery preparation for mucosal administration containing polymeric medicine |
| 04/25/2001 | EP1093521A2 Human transferases |
| 04/25/2001 | EP1093517A2 Neisseria meningitidis antigens and compositions |
| 04/25/2001 | EP1093465A2 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 04/25/2001 | EP1093464A2 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 04/25/2001 | EP1093382A2 Use of an amphipathic compound for providing an adjuvant to a subunit vaccine |
| 04/25/2001 | EP1093381A1 Antigenic peptides derived from telomerase |
| 04/25/2001 | CN1292827A Nucleic acid transfer vectors, compositions containing same and uses |
| 04/25/2001 | CN1292820A i (Neisseria meningitidis) antigens |
| 04/25/2001 | CN1292744A Folding pocket knife with lock |
| 04/25/2001 | CN1292706A Pneumococcal and meningococcal vaccines formulated with interleukin-12 |
| 04/25/2001 | CN1292688A Methods and compositions for detection and diagnosis of infectious diseases |
| 04/25/2001 | CN1292686A Delivery system to modulate immune response |
| 04/25/2001 | CN1292418A Heavy chain and light chain variable region gene of anti-C D 20 monoclonal antibody and its application |
| 04/25/2001 | CN1292386A New polypeptide-HRMT 35 and polynucleotide coding this polypeptide |
| 04/25/2001 | CN1292382A New polypeptide-ID-17 and polynucleotide coding this polypeptide |
| 04/24/2001 | US6222027 Molecules expressed in hippocampus |
| 04/24/2001 | US6222016 Amino acid sequence of protein involved in chromosome partitioning; drug screening of bacteriostats and bactericides; antibodies |
| 04/24/2001 | US6222014 Amino acid sequence of protein from ribonucleotide diphosphate reductase family; drug screening of bactericides and antibiotics |
| 04/24/2001 | US6222012 Isolated nonapeptides presented by HLA molecules, and uses thereof |
| 04/24/2001 | US6222011 Antigenic peptides |
| 04/24/2001 | US6222010 Amino acid sequence of nonapeptide; diagnosis; anticarcinogenic agents; antigens; antibodies |
| 04/24/2001 | US6221959 Polynucleotide, polymer complex |
| 04/24/2001 | US6221893 Administration of histamine for therapeutic purposes |
| 04/24/2001 | US6221664 Composite vaccine which contains antigen, antibody and recombinant DNA and its preparing method |
| 04/24/2001 | US6221660 Amino acid sequence; recombinant production; drug screening using membrane preparations |
| 04/24/2001 | US6221648 Lactococcus lactis transformed with t7 rna polymerase gene under control of lac inducible promoter and lacr gene and promoter specific for polymerase linked to coding sequence of desired polypeptide; vaccines; biological pest control |
| 04/24/2001 | US6221628 Nucleotide sequences coding preferential polypeptide for use in diagnosis and treatment atherosclerosis, ischemia, hypertension, restenosis and arterial inflammation |
| 04/24/2001 | US6221627 cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor |
| 04/24/2001 | US6221593 Diagnosing tumors in cells which express tumor rejection antigen; incubate sample with oligonucleotides, detect hybridization, hybridization is indicative of tumors |
| 04/24/2001 | US6221591 Determination of a genetic risk factor for infection and other diseases, and detection of activated phagocytes |
| 04/24/2001 | US6221577 Peptides which induce immune response and are useful in the diagnosis of urogenital tumors |
| 04/24/2001 | US6221378 Mixed micellar delivery system and method of preparation |
| 04/24/2001 | US6221376 Glial cell line-derived neurotrophic factor |
| 04/24/2001 | US6221367 Exposing a biologically active agent to a complexing perturbant to reversibly transform the biologically active agent to the intermediate state and to form a transportable supramolecular complex |
| 04/24/2001 | US6221366 Intestinal protozoal vaccines |
| 04/24/2001 | US6221365 NucA protein of Haemophilus influenzae |
| 04/24/2001 | US6221364 Recombinant mycobacteria auxotrophic for diaminopimelate |
| 04/24/2001 | US6221363 Vaccine for the prevention of lyme disease |
| 04/24/2001 | US6221362 A vaccine formula allowing the vaccination of avian species, in particular chickens. |
| 04/24/2001 | US6221361 A vector for the delivery of vaccine antigens and therapeutic agents to swine. |
| 04/24/2001 | US6221355 Anti-pathogen system and methods of use thereof |
| 04/24/2001 | US6221354 Feeding an antigen to a mammal, wherein the mammal is not allowed to ingest a fat-soluble component |